Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association

Thangam Venkatesan*, David J. Levinthal, Sally E Tarbell, Safwan S. Jaradeh, William L. Hasler, Robert M. Issenman, Kathleen A. Adams, Irene Sarosiek, Christopher D. Stave, Ravi N. Sharaf, Shahnaz Sultan, B. U.K. Li

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.

Original languageEnglish (US)
Article numbere13604
JournalNeurogastroenterology and Motility
Volume31
Issue numberS2
DOIs
StatePublished - Jun 1 2019

Fingerprint

Guidelines
aprepitant
zonisamide
coenzyme Q10
etiracetam
Tryptamines
Librarians
Sumatriptan
Meditation
Ondansetron
Serotonin Antagonists
Amitriptyline
Emergency Treatment
Riboflavin
Carnitine
Tricyclic Antidepressive Agents
Complementary Therapies
Clinical Protocols
Familial cyclic vomiting syndrome
Migraine Disorders

Keywords

  • abortive treatment
  • cyclic vomiting
  • emergency department
  • management
  • prophylaxis

ASJC Scopus subject areas

  • Physiology
  • Endocrine and Autonomic Systems
  • Gastroenterology

Cite this

Venkatesan, Thangam ; Levinthal, David J. ; Tarbell, Sally E ; Jaradeh, Safwan S. ; Hasler, William L. ; Issenman, Robert M. ; Adams, Kathleen A. ; Sarosiek, Irene ; Stave, Christopher D. ; Sharaf, Ravi N. ; Sultan, Shahnaz ; Li, B. U.K. / Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. In: Neurogastroenterology and Motility. 2019 ; Vol. 31, No. S2.
@article{d02930a1c1774ad0bd2af16252afca3e,
title = "Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association",
abstract = "The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.",
keywords = "abortive treatment, cyclic vomiting, emergency department, management, prophylaxis",
author = "Thangam Venkatesan and Levinthal, {David J.} and Tarbell, {Sally E} and Jaradeh, {Safwan S.} and Hasler, {William L.} and Issenman, {Robert M.} and Adams, {Kathleen A.} and Irene Sarosiek and Stave, {Christopher D.} and Sharaf, {Ravi N.} and Shahnaz Sultan and Li, {B. U.K.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/nmo.13604",
language = "English (US)",
volume = "31",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "S2",

}

Venkatesan, T, Levinthal, DJ, Tarbell, SE, Jaradeh, SS, Hasler, WL, Issenman, RM, Adams, KA, Sarosiek, I, Stave, CD, Sharaf, RN, Sultan, S & Li, BUK 2019, 'Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association', Neurogastroenterology and Motility, vol. 31, no. S2, e13604. https://doi.org/10.1111/nmo.13604

Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. / Venkatesan, Thangam; Levinthal, David J.; Tarbell, Sally E; Jaradeh, Safwan S.; Hasler, William L.; Issenman, Robert M.; Adams, Kathleen A.; Sarosiek, Irene; Stave, Christopher D.; Sharaf, Ravi N.; Sultan, Shahnaz; Li, B. U.K.

In: Neurogastroenterology and Motility, Vol. 31, No. S2, e13604, 01.06.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association

AU - Venkatesan, Thangam

AU - Levinthal, David J.

AU - Tarbell, Sally E

AU - Jaradeh, Safwan S.

AU - Hasler, William L.

AU - Issenman, Robert M.

AU - Adams, Kathleen A.

AU - Sarosiek, Irene

AU - Stave, Christopher D.

AU - Sharaf, Ravi N.

AU - Sultan, Shahnaz

AU - Li, B. U.K.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.

AB - The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.

KW - abortive treatment

KW - cyclic vomiting

KW - emergency department

KW - management

KW - prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=85067980501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067980501&partnerID=8YFLogxK

U2 - 10.1111/nmo.13604

DO - 10.1111/nmo.13604

M3 - Review article

VL - 31

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - S2

M1 - e13604

ER -